Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis

Zhang, X; Huang, HJ; Yang, DJ; Wang, P; Huang, X; Hu, ZQ; Zhang, Y; Yan, RL; Zhu, ZX; Cai, QP

Zhu, ZX; Cai, QP (corresponding author), Naval Med Univ, Changzheng Hosp, Dept Gastrointestinal Surg, Shanghai 200003, Peoples R China.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021; 20 ():

Abstract

Background: The optimal treatment for gastric cancer with peritoneal metastasis (GCPM) remains debatable. This study aimed to compare the efficacy and......

Full Text Link